Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Condition:   Type2 Diabetes Interventions:   Drug: Insulin Degludec U100;   Drug: Insulin Glargine Sponsors:   Weill Cornell Medical College in Qatar;   Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials